Printer Friendly
The Free Library
14,634,461 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Axiom Biotechnologies Receives Notice of Allowance on Two Patents for Cell-Based Compound Profiling.


Business Editors and Health/Medical Writers

SAN DIEGO--(BW HealthWire)--May 2, 2000

Axiom axiom, in mathematics and logic, general statement accepted without proof as the basis for logically deducing other statements (theorems). Examples of axioms used widely in mathematics are those related to equality (e.g.  Biotechnologies Inc. today announced that it has received Notice of Allowance from the United States Patent and Trademark Office The United States Patent and Trademark Office (PTO or USPTO) is an agency in the United States Department of Commerce that provides patent protection to inventors and businesses for their inventions, and trademark registration for product and intellectual property  on two U.S. patent applications for instrumentation and methods relating to relating to relate prepconcernant

relating to relate prepbezüglich +gen, mit Bezug auf +acc 
 pharmacology pharmacology, study of the changes produced in living animals by chemical substances, especially the actions of drugs, substances used to treat disease. Systematic investigation of the effects of drugs based on animal experimentation and the use of isolated and  profiling of compounds in cell-based assays. The two Allowed patent applications will expand the Company's patent portfolio by protecting the use of flow-based analytical systems for profiling compounds on living cells using a variety of cell-based approaches to assess receptor pharmacology, mechanism of action and toxicity endpoints.

"These two Allowances further reinforce Axiom's position as a leader in cell-based analyses for post-screening compound profiling," said Pandi Veerapandian, President & Chief Scientific Officer. "We are particularly pleased to extend and protect our flow-based approaches beyond fluorimetry into flow cytometry flow cytometry (flōˑ sī·tˑ·m  where the company can perform high efficiency analyses of cultured cell populations, as well as patient cell samples for pharmacogenomic applications."

The titles of the two patent applications are, "Apparatus and Method for Compound Profiling of Living Cells," and "Cell Flow Apparatus and Method for Real-Time Measurements of Cellular Response," and the Company expects these patents to issue later this year.

Axiom Biotechnologies is a privately-held biotechnology company focused on improving the efficiency of drug discovery by accelerating the process of lead profiling by applying an array of proprietary "hits-to-leads" technologies and assays. The company's patented flagship technology, the High Throughput Pharmacology System (HT-PS), combines proprietary natural cell-based assays, high throughput automated instrumentation and novel pharmacoinformatics and biomining tools to assess and prioritize potential lead compounds based on their functional pharmacological Pharmacological
Referring to therapy that relies on drugs.

Mentioned in: Pain Management


pharmacological, pharmacologic

pertaining to pharmacology.
 properties. Through collaborations with pharmaceutical and biotechnology companies Top 100 Biotechnology Companies
The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies.
, Axiom is committed to becoming the pharmaceutical industry's partner of choice in high throughput pharmacology.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 2, 2000
Words:287
Previous Article:Allianz Life Insurance Company of North America and Life USA Holding, Inc. Break Ground for New Corporate Headquarters in Golden Valley.
Next Article:eCatalystOne Appoints Say Kuan Tan Director of Operations in Asia; Developer of ePAID Non-Credit Based Internet Payment Method Establishes Presence...



Related Articles
Axiom Biotechnologies develops new, high-throughput screening paradigm for drug discovery on native cells.
Axiom, Zaiya And Nippon Kayaku Enter Anti-Cancer Drug Discovery Research Collaboration.
Axiom Completes Validation of High Throughput Pharmacology System Platform.
Axiom Completes Validation of High Throughput Pharmacology System Platform.
Axiom Biotechnologies Issued 2nd U.S. Patent On High Throughput Pharmacology System And Methods of Use.
Axiom Biotechnologies Inc. And Oxford Molecular Group Complete Development Of Cell Profiling Informatics Platform -- Profiler `99.
ENZO BIOCHEM GETS NEW PATENT ALLOWANCES IN U.S/CANADA.
Axiom Awarded Two Patents Covering Use of Flow Cytometry in Drug Discovery.
Axiom Biotechnologies Inc. Announces Collaboration with Sosei Co., Ltd. to Identify New Indications for Drug Candidates.
HOLLIS-EDEN GETS EUROPEAN PATENT RIGHTS FOR RADIATION DRUG.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles